{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:09:21Z","timestamp":1784268561832,"version":"3.55.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is characterized by sudden onset obsessive-compulsive disorder (OCD) symptoms in conjunction with other neuropsychiatric manifestations including disturbances in sleep, cognition, and behavior. Studies have revealed high rates of autoimmune and inflammatory markers\u2014as well as comorbid rheumatologic disease\u2014in patients with PANS. While published studies have suggested autoantibodies are common in PANS patients, the molecular targets of these autoantibodies (AAbs) remain poorly characterized. Here, we profile the AAbs in 224 plasma samples taken from 166 PANS patients during periods of active disease, or flares, compared to 83 pediatric healthy controls using custom Luminex microbead panels conjugated with highly curated antigens from common autoimmune diseases as well as cytokines and chemokines. We find that PANS patients exhibit increased prevalence of AAbs against autoantigens known to be targeted in scleroderma and GI\/endocrine autoimmune conditions. Furthermore, a subset of PANS patients exhibited AAbs against IFN-\u03bb, an important line of defense against infections at anatomic barriers. Among the 11 tested PANS plasma samples with IFN-\u03bb-binding AAbs, 9 showed detectable inhibition of IFN-\u03bb signaling, and 4 met our predefined stringent threshold for IFN-\u03bb-neutralizing activity, while no tested HC samples met this neutralization threshold. These findings support a link between autoimmunity and PANS, and may provide insight into a potential disease mechanism mediated by immune deficits at barrier surfaces in a subset of patients.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1832833","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:24Z","timestamp":1784267124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-\u03bb-neutralizing autoantibodies and common autoimmune disease autoantibodies in pediatric acute-onset neuropsychiatric syndrome"],"prefix":"10.3389","volume":"17","author":[{"given":"Xihui","family":"Yin","sequence":"first","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Frankovich","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, & Rheumatology, Department of Pediatrics, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Kalaycioglu","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael J.","family":"Burry","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Joo","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Science, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqian","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, & Rheumatology, Department of Pediatrics, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahare","family":"Farhadian","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, & Rheumatology, Department of Pediatrics, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Manko","sequence":"additional","affiliation":[{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Silverman","sequence":"additional","affiliation":[{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]},{"name":"Division of Child & Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Xie","sequence":"additional","affiliation":[{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]},{"name":"Division of Child & Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Tran","sequence":"additional","affiliation":[{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]},{"name":"Division of Child & Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelle","family":"Schlenk","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, & Rheumatology, Department of Pediatrics, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Stanford Immune Behavioral Health Clinic and Research Program, Stanford University & Stanford Children\u2019s Health","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Utz","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine","place":["Stanford, CA, United States"]},{"name":"Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler R.","family":"Prestwood","sequence":"additional","affiliation":[{"name":"Division of General Psychiatry and Psychology, Psychiatry Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine","place":["Stanford, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.91.4.706","article-title":"Sydenham's chorea: physical and psychological symptoms of St Vitus dance","volume":"91","author":"Swedo","year":"1993","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.2.246","article-title":"High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea","volume":"146","author":"Swedo","year":"1989","journal-title":"Am J Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810040041007","article-title":"Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases","volume":"46","author":"Swedo","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199511000-00008","article-title":"Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors","volume":"34","author":"Douglass","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198811000-00018","article-title":"Obsessive compulsive disorder in adolescence: an epidemiological study","volume":"27","author":"Flament","year":"1988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199407000-00002","article-title":"Frequency of obsessive-compulsive disorder in a community sample of young adolescents","volume":"33","author":"Valleni-Basile","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B7","article-title":"Pediatric OCD: Clinical course, phenomenology, and assessment","volume-title":"Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment","author":"Ginsberg","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference","volume":"25","author":"Chang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0665.1000113","article-title":"From research subgroup to clinical syndrome: Modifying the PANDAS criteria to define PANS (pediatric acute-onset neuropsychiatric syndrome)","volume":"2","author":"Swedo","year":"2012","journal-title":"Pediatr Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2024.04.26.24306193","article-title":"Prevalence of neurological soft signs at presentation in pediatric acute-onset neuropsychiatric syndrome","author":"Zebrack","year":"2024","journal-title":"medRxiv"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.09.071","article-title":"Post-infectious autoimmune disorders: Sydenham's chorea, PANDAS and beyond","volume":"1617","author":"Williams","year":"2015","journal-title":"Brain Res"},{"key":"B12","article-title":"PANDAS as a post-Streptococcal autoimmune neuropsychiatric form of OCD","volume-title":"Obsessive-Compulsive Disorder: Phenomenology, Pathophysiology, and Treatment","author":"Swedo","year":"2017"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21688","article-title":"Development of autoimmune diseases among children with pediatric acute-onset neuropsychiatric syndrome","volume":"7","author":"Ma","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-1103-3","article-title":"Hypoferritinemia and iron deficiency in youth with pediatric acute-onset neuropsychiatric syndrome","volume":"89","author":"Chan","year":"2021","journal-title":"Pediatr Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4063","article-title":"Association of pediatric acute-onset neuropsychiatric syndrome with microstructural differences in brain regions detected via diffusion-weighted magnetic resonance imaging","volume":"3","author":"Zheng","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7222","article-title":"Continued presence of period limb movements during REM sleep in patients with chronic static pediatric acute-onset neuropsychiatric syndrome (PANS)","volume":"14","author":"Santoro","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1176\/appi.ajp.2020.19070698","article-title":"Antibodies from children with PANDAS bind specifically to striatal cholinergic interneurons and alter their activity","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.07.044","article-title":"Elevated antibody binding to striatal cholinergic interneurons in patients with pediatric acute-onset neuropsychiatric syndrome","volume":"122","author":"Xu","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.163150","article-title":"Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness","volume":"8","author":"Feng","year":"2023","journal-title":"JCI Insight"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06670-0","article-title":"Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study","volume":"42","author":"Tesch","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in approximately 40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/v15051215","article-title":"Autoantibodies to interferons in infectious diseases","volume":"15","author":"Quiros-Roldan","year":"2023","journal-title":"Viruses"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01786.x","article-title":"Recurrent herpes simplex virus infection in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy associated with L29P and IVS9-1G>C compound heterozygous autoimmune regulator gene mutations","volume":"261","author":"Nagafuchi","year":"2007","journal-title":"J Intern Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108851","article-title":"Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections","volume":"231","author":"Hetemaki","year":"2021","journal-title":"Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222549","article-title":"Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-alpha","volume":"81","author":"Mathian","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2023.0003","article-title":"Autoantibodies neutralizing type III interferons are uncommon in patients with severe coronavirus disease 2019 pneumonia","volume":"43","author":"Vanker","year":"2023","journal-title":"J Interferon Cytokine Res"},{"key":"B34","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1977.03270510035017","article-title":"Clinical history as a screening test for ankylosing spondylitis","volume":"237","author":"Calin","year":"1977","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528465","article-title":"Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients","volume":"16","author":"Feng","year":"2025","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0193","article-title":"Effect of early and prophylactic nonsteroidal anti-inflammatory drugs on flare duration in pediatric acute-onset neuropsychiatric syndrome: an observational study of patients followed by an academic community-based pediatric acute-onset neuropsychiatric syndrome clinic","volume":"27","author":"Brown","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0139","article-title":"Pediatric acute-onset neuropsychiatric syndrome response to oral corticosteroid bursts: an observational study of patients in an academic community-based PANS clinic","volume":"27","author":"Brown","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/BF02230332","article-title":"Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases","volume":"15","author":"Blockmans","year":"1996","journal-title":"Clin Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030002","article-title":"Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach","volume":"3","author":"Lunardi","year":"2006","journal-title":"PloS Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.7.553","article-title":"Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis","volume":"45","author":"Kahan","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000232945","article-title":"Human parvovirus B19 (B19V) infection in systemic sclerosis patients","volume":"52","author":"Zakrzewska","year":"2009","journal-title":"Intervirology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.0007-0963.2004.05930.x","article-title":"Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin","volume":"150","author":"Ohtsuka","year":"2004","journal-title":"Br J Dermatol"},{"key":"B46","article-title":"Genetic and environmental factors in systemic sclerosis","volume":"4","author":"Fox","year":"1992","journal-title":"Curr Opin Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PloS Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1002","article-title":"Temporal dynamics of anti\u2013type 1 interferon autoantibodies in patients with coronavirus disease 2019","volume":"75","author":"Shaw","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01703-09","article-title":"Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo","volume":"84","author":"Jewell","year":"2010","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PloS Pathog"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-lambda determines the intestinal epithelial antiviral host defense","volume":"108","author":"Pott","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PloS Pathog"},{"key":"B55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-lambda: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"284ra59","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-lambda restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.06.017","article-title":"Antibody-mediated neuronal cell signaling in behavior and movement disorders","volume":"179","author":"Kirvan","year":"2006","journal-title":"J Neuroimmunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100288","article-title":"Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms","volume":"2","author":"Song","year":"2021","journal-title":"Cell Rep Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160682","article-title":"Antimelanoma differentiation-associated gene 5 antibody: Expanding the clinical spectrum in North American patients with dermatomyositis","volume":"44","author":"Moghadam-Kia","year":"2017","journal-title":"J Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0798","article-title":"Risk of thyroid disease in individuals with celiac disease","volume":"93","author":"Elfstr\u00f6m","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16454","article-title":"Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease\u2014an observational study","volume":"27","author":"Edelman","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/08916930701619169","article-title":"Autoantibodies in type 1 diabetes","volume":"41","author":"Taplin","year":"2008","journal-title":"Autoimmunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: Clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:45:26Z","timestamp":1784267126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1832833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2026.1832833"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1832833","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1832833"}}